Sandoz launches once-daily generic tacrolimus for transplant patients in Europe
  • Sandoz is first and only company offering complete range of dosing options in several European markets*, with 2 mg capsule allowing for fine dose titration
  • Sandoz 2 mg slow-release capsule offers simplified once-daily treatment protocol that may reduce a patient’s daily pill burden1
  • Launch builds on Sandoz experience with Adoport® — #1 twice-daily generic tacrolimus in Europe2

Holzkirchen, June 4, 2020 – Sandoz today announced the launch of once-daily generic tacrolimus capsules known as Dailiport® in …

/by
Hungary approves Sandoz’s Airflusal® Forspiro®

Holzkirchen, Germany, January 16, 2014 – Sandoz announced it has received marketing authorization in Hungary for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD.

The product was first approved in Denmark on December 18th, 2013 with subsequent marketing authorizations received earlier this week also in Germany and Sweden.

The new product offers the proven combination of salmeterol (a long-acting inhaled β2-agonist) and fluticasone (an inhaled corticosteroid) in an innovative inhalation device.

Hungary has approved the 50- …

/by